Through the Eyes of Patients: Understanding Treatment Burden of Intravitreal Anti-VEGF Injections for nAMD Patients in Norway.

Reitan, Gudrun; Kjellevold Haugen, Inga Britt; Andersen, Kristoffer; Bragadottir, Ragnheidur; Bindesbøll, Christian

Reitan, Gudrun; Kjellevold Haugen, Inga Britt; Andersen, Kristoffer; Bragadottir, Ragnheidur; Bindesbøll, Christian.

Afiliación

Reitan G; Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Kjellevold Haugen IB; Department of Research, The Norwegian Association of the Blind and Partially Sighted, Oslo, Norway.
Andersen K; Roche Norway, F Hoffmann-La Roche AG, Oslo, Norway.
Bragadottir R; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Bindesbøll C; Department of Ophthalmology, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Clin Ophthalmol ; 17: 1465-1474, 2023.

Article en En | MEDLINE | ID: mdl-37256195

Palabras clave

burden; intravitreal; nAMD; quality of life; questionnaire; retina

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Clin Ophthalmol Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google